Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)

PHASE2CompletedINTERVENTIONAL
Enrollment

257

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

APD405

IV

DRUG

Placebo

IV

Trial Locations (18)

27710

Duke University Medical Center, Durham

67000

Hautepierre Hospital, Strasbourg

69500

Hôpital mère enfant, Bron

77024

Memorial Hermann-Memorial City Hospital, Houston

94115

UCSF Medical Center at Mt Zion, San Francisco

Unknown

University Hospital, Besançon

Hôpital Huriez, Lille

University Hospital, Nancy

Hôpital FOCH, Paris

University Hospital, Reims

Charité - Universitätsmedizin, Berlin

Universität Heidelberg, Heidelberg

University of Leipzig, Leipzig

Klinikum Ludwigshafen, Ludwigshafen

Philipps University, Marburg

University Hospitals of Würzburg, Würzburg

Geneva University Hospitals, Geneva

Centre Hospitalier Universitaire Vaudois, Lausanne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Acacia Pharma Ltd

INDUSTRY